Terms: = Sarcomas AND MYD88, Q99836, MYD88D, 4615
17 results:
1. miR-199a-3p suppresses neuroinflammation by directly targeting myd88 in a mouse model of bone cancer pain.
Saadh MJ; Rashed AB; Jamal A; Castillo-Acobo RY; Kamal MA; Cotrina-Aliaga JC; Gonzáles JLA; Alothaim AS; Alhoqail WA; Ahmad F; Lakshmaiya N; Amin AH; Younus DG; Rojas GGR; Bahrami A; Akhavan-Sigari R
Life Sci; 2023 Nov; 333():122139. PubMed ID: 37783266
[TBL] [Abstract] [Full Text] [Related]
2. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
[TBL] [Abstract] [Full Text] [Related]
3. Human γδ T cells induce CD8
Wang S; Li H; Chen T; Zhou H; Zhang W; Lin N; Yu X; Lou Y; Li B; Yinwang E; Wang Z; Wang K; Xue Y; Qu H; Lin P; Sun H; Teng W; Mou H; Chai X; Cai Z; Ye Z
Cancer Immunol Immunother; 2023 Jun; 72(6):1803-1821. PubMed ID: 36680568
[TBL] [Abstract] [Full Text] [Related]
4. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract] [Full Text] [Related]
5. TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway.
Gruffaz M; Vasan K; Tan B; Ramos da Silva S; Gao SJ
Cancer Res; 2017 Dec; 77(24):7094-7108. PubMed ID: 29051178
[TBL] [Abstract] [Full Text] [Related]
6. Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.
Wang J; Grishin AV; Ford HR
J Immunol; 2016 Jun; 196(12):5130-7. PubMed ID: 27194788
[TBL] [Abstract] [Full Text] [Related]
7. Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (myd88) Expression via Modulation of Its RNA.
Lingel A; Ehlers E; Wang Q; Cao M; Wood C; Lin R; Zhang L
J Virol; 2016 Jan; 90(1):180-8. PubMed ID: 26468534
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.
Yang D; Chen W; Xiong J; Sherrod CJ; Henry DH; Dittmer DP
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4762-8. PubMed ID: 25341731
[TBL] [Abstract] [Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88.
Zhao Q; Liang D; Sun R; Jia B; Xia T; Xiao H; Lan K
J Virol; 2015 Jan; 89(1):415-27. PubMed ID: 25320320
[TBL] [Abstract] [Full Text] [Related]
11. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.
Futosi K; Fodor S; Mócsai A
Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067
[TBL] [Abstract] [Full Text] [Related]
12. Neutrophil cell surface receptors and their intracellular signal transduction pathways.
Futosi K; Fodor S; Mócsai A
Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464
[TBL] [Abstract] [Full Text] [Related]
13. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.
Yamazaki T; Hannani D; Poirier-Colame V; Ladoire S; Locher C; Sistigu A; Prada N; Adjemian S; Catani JP; Freudenberg M; Galanos C; André F; Kroemer G; Zitvogel L
Cell Death Differ; 2014 Jan; 21(1):69-78. PubMed ID: 23811849
[TBL] [Abstract] [Full Text] [Related]
14. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract] [Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and myd88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
[TBL] [Abstract] [Full Text] [Related]
16. Toll-like receptor 4-mediated c-Jun N-terminal kinase activation induces gp96 cell surface expression via AIMP1 phosphorylation.
Kim G; Han JM; Kim S
Biochem Biophys Res Commun; 2010 Jun; 397(1):100-5. PubMed ID: 20510162
[TBL] [Abstract] [Full Text] [Related]
17. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Apetoh L; Ghiringhelli F; Tesniere A; Obeid M; Ortiz C; Criollo A; Mignot G; Maiuri MC; Ullrich E; Saulnier P; Yang H; Amigorena S; Ryffel B; Barrat FJ; Saftig P; Levi F; Lidereau R; Nogues C; Mira JP; Chompret A; Joulin V; Clavel-Chapelon F; Bourhis J; André F; Delaloge S; Tursz T; Kroemer G; Zitvogel L
Nat Med; 2007 Sep; 13(9):1050-9. PubMed ID: 17704786
[TBL] [Abstract] [Full Text] [Related]
